{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:49:58Z","timestamp":1783352998357,"version":"3.54.6"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["E-Rare Joint Transnational Call JTC 2018"],"award-info":[{"award-number":["E-Rare Joint Transnational Call JTC 2018"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["305697"],"award-info":[{"award-number":["305697"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Myotonic dystrophy type 1 (DM1) is an incurable multisystem disease caused by a CTG-repeat expansion in the DM1 protein kinase (\n                      <jats:italic>DMPK<\/jats:italic>\n                      ) gene. The OPTIMISTIC clinical trial demonstrated positive and heterogenous effects of cognitive behavioral therapy (CBT) on the capacity for activity and social participations in DM1 patients. Through a process of reverse engineering, this study aims to identify druggable molecular biomarkers associated with the clinical improvement in the OPTIMISTIC cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on full blood samples collected during OPTIMISTIC, we performed paired mRNA sequencing for 27 patients before and after the CBT intervention. Linear mixed effect models were used to identify biomarkers associated with the disease-causing CTG expansion and the mean clinical improvement across all clinical outcome measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 608 genes for which their expression was significantly associated with the CTG-repeat expansion, as well as 1176 genes significantly associated with the average clinical response towards the intervention. Remarkably, all 97 genes associated with both returned to more normal levels in patients who benefited the most from CBT. This main finding has been replicated based on an external dataset of mRNA data of DM1 patients and controls, singling these genes out as candidate biomarkers for therapy response. Among these candidate genes were\n                      <jats:italic>DNAJB12<\/jats:italic>\n                      ,\n                      <jats:italic>HDAC5<\/jats:italic>\n                      , and\n                      <jats:italic>TRIM8<\/jats:italic>\n                      , each belonging to a protein family that is being studied in the context of neurological disorders or muscular dystrophies. Across the different gene sets, gene pathway enrichment analysis revealed disease-relevant impaired signaling in, among others, insulin-, metabolism-, and immune-related pathways. Furthermore, evidence for shared dysregulations with another neuromuscular disease, Duchenne muscular dystrophy, was found, suggesting a partial overlap in blood-based gene dysregulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DM1-relevant disease signatures can be identified on a molecular level in peripheral blood, opening new avenues for drug discovery and therapy efficacy assessments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-022-02591-y","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T20:02:32Z","timestamp":1668024152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood"],"prefix":"10.1186","volume":"20","author":[{"given":"Remco T. P.","family":"van Cruchten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebl","family":"van As","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Glennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel G. M.","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4450-3112","authenticated-orcid":false,"given":"Peter A. C.","family":"\u2018t Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the OPTIMISTIC consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ReCognitION consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Okkersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Jimenez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Wenninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Daidj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Littleford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Monckton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Catt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C G","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hapca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P T","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bassez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Treweek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick G.","family":"Wansink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Impens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gabriels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymeric","family":"Ravel-Chapuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Nieuwenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Furling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Baak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Gourdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Martinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisa","family":"Neault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Duchesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Salz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Baghdoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu Mary","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Spendiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Manta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"issue":"4","key":"2591_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","volume":"1852","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R. Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta Mol basis Dis. 2015;1852(4):594\u2013606.","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"4","key":"2591_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell. 1992;68(4):799\u2013808.","journal-title":"Cell."},{"issue":"5049","key":"2591_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.1546325","volume":"255","author":"M Mahadevan","year":"1992","unstructured":"Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2032 untranslated region of the gene. Science. 1992;255(5049):1253\u20135.","journal-title":"Science."},{"issue":"5049","key":"2591_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1126\/science.1546326","volume":"255","author":"YH Fu","year":"1992","unstructured":"Fu YH, Pizzuti A, Fenwick RG, King J, Rajnarayan S, Dunne PW, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255(5049):1256\u20138.","journal-title":"Science."},{"issue":"11","key":"2591_CR5","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41431-018-0156-9","volume":"26","author":"SA Cumming","year":"2018","unstructured":"Cumming SA, Hamilton MJ, Robb Y, Gregory H, McWilliam C, Cooper A, et al. De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1. Eur J Hum Genet. 2018;26(11):1635\u201347.","journal-title":"Eur J Hum Genet"},{"issue":"49","key":"2591_CR6","doi-asserted-by":"publisher","first-page":"31079","DOI":"10.1074\/jbc.272.49.31079","volume":"272","author":"M Napiera\u0142a","year":"1997","unstructured":"Napiera\u0142a M, Krzyzosiak WJ. CUG repeats present in myotonin kinase RNA form metastable \u201cslippery\u201d hairpins. J Biol Chem. 1997;272(49):31079\u201385.","journal-title":"J Biol Chem"},{"issue":"7","key":"2591_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/hmg\/11.7.805","volume":"11","author":"M Fardaei","year":"2002","unstructured":"Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet. 2002;11(7):805\u201314.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2591_CR8","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1261\/rna.610607","volume":"13","author":"MB Warf","year":"2007","unstructured":"Warf MB, Berglund JA. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA. 2007;13(12):2238\u201351.","journal-title":"RNA."},{"issue":"4","key":"2591_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1261\/rna.068940.118","volume":"25","author":"RTP van Cruchten","year":"2019","unstructured":"van Cruchten RTP, Wieringa B, Wansink DG. Expanded CUG repeats in DMPK transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences. RNA. 2019;25(4):481\u201395.","journal-title":"RNA."},{"issue":"6","key":"2591_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ana.23992","volume":"74","author":"M Nakamori","year":"2013","unstructured":"Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, et al. Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol. 2013;74(6):862\u201372.","journal-title":"Ann Neurol"},{"issue":"8","key":"2591_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/hmg\/ddy432","volume":"28","author":"ET Wang","year":"2018","unstructured":"Wang ET, Treacy D, Eichinger K, Struck A, Estabrook J, Wang TT, et al. Transcriptome alterations in myotonic dystrophy skeletal muscle and heart. Hum Mol Genet. 2018;28(8):1312\u201321.","journal-title":"Hum Mol Genet"},{"key":"2591_CR12","doi-asserted-by":"crossref","unstructured":"Otero BA, Poukalov K, Hildebrandt RP, Thornton CA, Jinnai K, Fujimura H, et al. Transcriptome alterations in myotonic dystrophy frontal cortex. Cell Rep. 2021;34(3):108634.","DOI":"10.1016\/j.celrep.2020.108634"},{"issue":"10","key":"2591_CR13","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1212\/WNL.0000000000008056","volume":"93","author":"SA Cumming","year":"2019","unstructured":"Cumming SA, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, et al. Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology. 2019;93(10):e995\u2013e1009.","journal-title":"Neurology."},{"issue":"1","key":"2591_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","volume":"10","author":"A Mankodi","year":"2002","unstructured":"Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell. 2002;10(1):35\u201344.","journal-title":"Mol Cell"},{"issue":"1","key":"2591_CR15","doi-asserted-by":"publisher","first-page":"11067","DOI":"10.1038\/ncomms11067","volume":"7","author":"F Freyermuth","year":"2016","unstructured":"Freyermuth F, Rau F, Kokunai Y, Linke T, Sellier C, Nakamori M, et al. Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy. Nat Commun. 2016;7(1):11067.","journal-title":"Nat Commun"},{"issue":"1","key":"2591_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ng704","volume":"29","author":"RS Savkur","year":"2001","unstructured":"Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet. 2001;29(1):40\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"2591_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12891-019-2458-7","volume":"20","author":"M-P Roussel","year":"2019","unstructured":"Roussel M-P, Morin M, Gagnon C, Duchesne E. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review. BMC Musculoskelet Disord. 2019;20(1):101.","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"2591_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1474-4422(18)30203-5","volume":"17","author":"K Okkersen","year":"2018","unstructured":"Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S, et al. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol. 2018;17(8):671\u201380.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2591_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1113\/JP277123","volume":"597","author":"A Manta","year":"2019","unstructured":"Manta A, Stouth DW, Xhuti D, Chi L, Rebalka IA, Kalmar JM, et al. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice. J Physiol. 2019;597(5):1361\u201381.","journal-title":"J Physiol"},{"key":"2591_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.omtn.2020.11.014","volume":"23","author":"N Hu","year":"2020","unstructured":"Hu N, Kim E, Antoury L, Li J, Gonz\u00e1lez-P\u00e9rez P, Rutkove SB, et al. Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy. Mol Ther Nucleic Acids. 2020;23:393\u2013405.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"2591_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3233\/JND-210634","volume":"8","author":"D van As","year":"2021","unstructured":"van As D, Okkersen K, Bassez G, Schoser B, Lochm\u00fcller H, Glennon JC, et al. Clinical outcome evaluations and CBT response prediction in myotonic dystrophy. J Neuromuscul Dis. 2021;8(6):1031\u201346.","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"2591_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013328","volume":"13","author":"M Signorelli","year":"2021","unstructured":"Signorelli M, Ebrahimpoor M, Veth O, Hettne K, Verwey N, Garc\u00eda-Rodr\u00edguez R, et al. Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients. EMBO Mol Med. 2021;13(4):e13328.","journal-title":"EMBO Mol Med"},{"issue":"8","key":"2591_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","volume":"16","author":"LM Byrne","year":"2017","unstructured":"Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, et al. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis. Lancet Neurol. 2017;16(8):601\u20139.","journal-title":"Lancet Neurol"},{"issue":"2","key":"2591_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biopsych.2010.03.017","volume":"68","author":"S Spijker","year":"2010","unstructured":"Spijker S, Van Zanten JS, De Jong S, Penninx BWJH, Van Dyck R, Zitman FG, et al. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry. 2010;68(2):179\u201386.","journal-title":"Biol Psychiatry"},{"key":"2591_CR25","doi-asserted-by":"crossref","unstructured":"Sznajder \u0141J, Scotti MM, Shin J, Taylor K, Ivankovic F, Nutter CA, et al. Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood. Nat Commun. 2020;11(1):2022.","DOI":"10.1038\/s41467-020-15962-x"},{"issue":"8","key":"2591_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/archneur.63.8.1149","volume":"63","author":"CR Heatwole","year":"2006","unstructured":"Heatwole CR, Miller J, Martens B, Moxley RT. Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1. Arch Neurol. 2006;63(8):1149\u201353.","journal-title":"Arch Neurol"},{"key":"2591_CR27","doi-asserted-by":"crossref","unstructured":"Hermans MCE, Hoeijmakers JGJ, Faber CG, Merkies ISJ. Reconstructing the Rasch-built myotonic dystrophy type 1 activity and participation scale. PLoS One. 2015;10(10):e0139944.","DOI":"10.1371\/journal.pone.0139944"},{"key":"2591_CR28","unstructured":"Full blood mRNA sequencing of myotonic dystrophy type 1 patients after cognitive behavioural therapy. EGA-Archive. https:\/\/identifiers.org\/ega.dataset:EGAD00001005830. Accessed 01 May 2022."},{"key":"2591_CR29","doi-asserted-by":"crossref","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011;17(1):10\u20132.","DOI":"10.14806\/ej.17.1.200"},{"issue":"1","key":"2591_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics."},{"issue":"16","key":"2591_CR31","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics."},{"issue":"3","key":"2591_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 2017;27(3):491\u20139.","journal-title":"Genome Res"},{"issue":"16","key":"2591_CR33","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang L, Wang S, Li W. RSeQC: quality control of RNA-seq experiments. Bioinformatics. 2012;28(16):2184\u20135.","journal-title":"Bioinformatics."},{"issue":"2","key":"2591_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics."},{"key":"2591_CR35","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","volume":"6","author":"J Racle","year":"2017","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6:e26476.","journal-title":"Elife"},{"issue":"1","key":"2591_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34.","journal-title":"Genome Med"},{"issue":"1","key":"2591_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"key":"2591_CR38","doi-asserted-by":"publisher","unstructured":"Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA, et al. Scaling accurate genetic variant discovery to tens of thousands of samples [Internet]. bioRxiv [Preprint]. 2017 [cited 2021 Sep 01]. https:\/\/doi.org\/10.1101\/201178.","DOI":"10.1101\/201178"},{"key":"2591_CR39","unstructured":"Broad Institute. Picard toolkit. GitHub repository. http:\/\/broadinstitute.github.io\/picard\/. Accessed 01 May 2021."},{"issue":"51","key":"2591_CR40","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci U S A. 2014;111(51):E5593\u2013601.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2591_CR41","unstructured":"Wang ET, Treacy D, Wang TT, Estabrook J, Day J, Brook D, et al. Transcriptional profiling of myotonic dystrophy muscle and heart. Gene Expression Omnibus. 2016. https:\/\/identifiers.org\/geo:GSE86356. Accessed 01 Feb 2021."},{"key":"2591_CR42","unstructured":"Charlet-Berguerand N, Takahashi M, Jost B. RNA sequencing of heart samples of myotonic dystrophic (DM1) patients. Gene Expression Omnibus. 2015. https:\/\/identifiers.org\/geo:GSE67812. Accessed 01 Feb 2021."},{"key":"2591_CR43","doi-asserted-by":"crossref","unstructured":"Otero BA, Poukalov K, Hildebrandt RP, Thornton CA, Jinnai K, Fujimara H, et al. Transcriptome alterations in myotonic dystrophy frontal cortex. Gene Expression Omnibus. 2020. https:\/\/identifiers.org\/geo:GSE157428. Accessed 01 Feb 2021.","DOI":"10.1101\/2020.09.09.284505"},{"key":"2591_CR44","doi-asserted-by":"crossref","unstructured":"Sznajder \u0141J, Scotti MM, Shin J, Taylor K, Ivankovic F, Nutter CA, et al. Loss of MBNL1 induces RNA mis-processing in the thymus and peripheral blood. Gene Expression Omnibus. 2020. https:\/\/identifiers.org\/geo:GSE138691. Accessed 01 Feb 2021.","DOI":"10.1038\/s41467-020-15962-x"},{"key":"2591_CR45","unstructured":"Schwender H, M\u00fcller T. Computing thousands of test statistics simultaneously in R. Stat. Comput Graph.\u00a02007;18(1):5\u201311."},{"key":"2591_CR46","volume-title":"R: a language and environment for statistical computing","author":"RC Team","year":"2019","unstructured":"Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2019. https:\/\/www.R-project.org"},{"issue":"1","key":"2591_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics."},{"issue":"7","key":"2591_CR48","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2591_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1\u201348.","journal-title":"J Stat Softw"},{"issue":"13","key":"2591_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82(13):1\u201326.","journal-title":"J Stat Softw"},{"issue":"1","key":"2591_CR51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"issue":"10","key":"2591_CR52","first-page":"1","volume":"15","author":"S Zhao","year":"2014","unstructured":"Zhao S, Guo Y, Sheng Q, Shyr Y. Heatmap3: an improved heatmap package with more powerful and convenient features. BMC Bioinforma. 2014;15(10):1\u20132.","journal-title":"BMC Bioinforma"},{"key":"2591_CR53","first-page":"316","volume":"56","author":"T Wei","year":"2017","unstructured":"Wei T, Simko V, Levy M, Xie Y, Jin Y, Zemla J. R package \u201ccorrplot\u201d: visualization of a correlation matrix. Statistician. 2017;56:316\u201324.","journal-title":"Statistician."},{"key":"2591_CR54","unstructured":"Revelle W. psych: Procedures for Psychological, Psychometric, and Personality Research. Northwestern University, Evanston, Illinois. R package. https:\/\/CRAN.R-project.org\/package=psych. Accessed 01 May 2021."},{"key":"2591_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016."},{"issue":"1","key":"2591_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics. 2011;12(1):35.","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"2591_CR57","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, et al. G:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47(W1):W191\u20138.","journal-title":"Nucleic Acids Res"},{"key":"2591_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1148\/radiol.2020192518","volume":"297","author":"L Heskamp","year":"2020","unstructured":"Heskamp L, Okkersen K, van Nimwegen MV, Ploegmakers MJ, Bassez G, Deux JF, et al. Quantitative muscle MRI depicts increased muscle mass after a behavioral change in myotonic dystrophy type 1. Radiology. 2020;297:132\u201342.","journal-title":"Radiology"},{"issue":"8","key":"2591_CR59","first-page":"111","volume":"18","author":"E Grazioli","year":"2017","unstructured":"Grazioli E, Dimauro I, Mercatelli N, Wang G, Pitsiladis Y, Di Luigi L, et al. Physical activity in the prevention of human diseases: role of epigenetic modifications. BMC Genomics. 2017;18(8):111\u201323.","journal-title":"BMC Genomics"},{"key":"2591_CR60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fgene.2018.00257","volume":"9","author":"JP Jim\u00e9nez","year":"2018","unstructured":"Jim\u00e9nez JP, Botto A, Herrera L, Leighton C, Rossi JL, Quevedo Y, et al. Psychotherapy and genetic neuroscience: an emerging dialog. Front Genet. 2018;9:257.","journal-title":"Front Genet"},{"issue":"4","key":"2591_CR61","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1053\/j.gastro.2016.06.051","volume":"151","author":"D Li","year":"2016","unstructured":"Li D, Achkar JP, Haritunians T, Jacobs JP, Hui KY, D\u2019Amato M, et al. A pleiotropic missense variant in SLC39A8 is associated with Crohn\u2019s disease and human gut microbiome composition. Gastroenterology. 2016;151(4):724\u201332.","journal-title":"Gastroenterology."},{"issue":"7","key":"2591_CR62","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1172\/JCI23108","volume":"114","author":"MJ Brady","year":"2004","unstructured":"Brady MJ. IRS2 takes center stage in the development of type 2 diabetes. J Clin Invest. 2004;114(7):886.","journal-title":"J Clin Invest"},{"issue":"3","key":"2591_CR63","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41589-020-00723-0","volume":"17","author":"Y Liu","year":"2021","unstructured":"Liu Y, Jurczak MJ, Lear TB, Lin B, Larsen MB, Kennerdell JR, et al. A Fbxo48 inhibitor prevents pAMPK\u03b1 degradation and ameliorates insulin resistance. Nat Chem Biol. 2021;17(3):298\u2013306.","journal-title":"Nat Chem Biol"},{"key":"2591_CR64","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis S, Okkersen K, Widomska J, Blom P, \u2018t Hoen PAC, van Engelen B, et al. Insulin signaling as a key moderator in myotonic dystrophy type 1. Front Neurol. 2019;10:1229.","DOI":"10.3389\/fneur.2019.01229"},{"issue":"10","key":"2591_CR65","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/jpepsy\/jsz064","volume":"44","author":"LD Gulley","year":"2019","unstructured":"Gulley LD, Shomaker LB, Kelly NR, Chen KY, Stice E, Olsen CH, et al. Indirect effects of a cognitive-behavioral intervention on adolescent weight and insulin resistance through decreasing depression in a randomized controlled trial. J Pediatr Psychol. 2019;44(10):1163\u201373.","journal-title":"J Pediatr Psychol"},{"issue":"10","key":"2591_CR66","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/brain\/awy231","volume":"141","author":"G Bassez","year":"2018","unstructured":"Bassez G, Audureau E, Hogrel JY, Arrouasse R, Baghdoyan S, Bhugaloo H, et al. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. Brain. 2018;141(10):2855\u201365.","journal-title":"Brain."},{"issue":"APR","key":"2591_CR67","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3389\/fimmu.2019.00737","volume":"10","author":"J Zhong","year":"2019","unstructured":"Zhong J, Shi G. Editorial: Regulation of inflammation in chronic disease. Front Immunol. 2019;10(APR):737.","journal-title":"Front Immunol"},{"issue":"6","key":"2591_CR68","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2217\/fnl.09.55","volume":"4","author":"JM Gottesfeld","year":"2009","unstructured":"Gottesfeld JM, Pandolfo M. Development of histone deacetylase inhibitors as therapeutics for neurological disease. Future Neurol. 2009;4(6):775.","journal-title":"Future Neurol"},{"key":"2591_CR69","doi-asserted-by":"crossref","unstructured":"Thakur SS, Swiderski K, Ryall JG, Lynch GS. Therapeutic potential of heat shock protein induction for muscular dystrophy and other muscle wasting conditions. Philos Trans R Soc B Biol Sci. 2018;373(1738):20160528.","DOI":"10.1098\/rstb.2016.0528"},{"issue":"7","key":"2591_CR70","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/jamaneurol.2013.469","volume":"70","author":"J Alloush","year":"2013","unstructured":"Alloush J, Weisleder N. TRIM proteins in therapeutic membrane repair of muscular dystrophy. JAMA Neurol. 2013;70(7):928\u201331.","journal-title":"JAMA Neurol"},{"key":"2591_CR71","doi-asserted-by":"crossref","unstructured":"Zhao L, Son JS, Wang B, Tian Q, Chen Y, Liu X, et al. Retinoic acid signalling in fibro\/adipogenic progenitors robustly enhances muscle regeneration. EBioMedicine. 2020;60:103020.","DOI":"10.1016\/j.ebiom.2020.103020"},{"issue":"1","key":"2591_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pharmthera.2013.03.009","volume":"139","author":"GV Halade","year":"2013","unstructured":"Halade GV, Jin YF, Lindsey ML. Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol Ther. 2013;139(1):32.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2591_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17982-y","volume":"7","author":"A Lourbakos","year":"2017","unstructured":"Lourbakos A, Yau N, De Bruijn P, Hiller M, Kozaczynska K, Jean-Baptiste R, et al. Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne. Sci Report. 2017;7(1):1\u201310.","journal-title":"Sci Report"},{"key":"2591_CR74","unstructured":"GTEx Portal [Internet]. Available from: https:\/\/www.gtexportal.org\/home\/gene\/DMPK. [Cited 2022 Jul 13]."},{"issue":"1","key":"2591_CR75","doi-asserted-by":"publisher","DOI":"10.4161\/rdis.26555","volume":"1","author":"C Wei","year":"2013","unstructured":"Wei C, Jones K, Timchenko NA, Timchenko L. GSK3\u03b2 is a new therapeutic target for myotonic dystrophy type 1. Rare Dis. 2013;1(1):e26555.","journal-title":"Rare Dis"},{"issue":"4","key":"2591_CR76","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1096\/fj.201700700R","volume":"32","author":"C Wei","year":"2018","unstructured":"Wei C, Stock L, Valanejad L, Zalewski ZA, Karns R, Puymirat J, et al. Correction of GSK3\u03b2 at young age prevents muscle pathology in mice with myotonic dystrophy type 1. FASEB J. 2018;32(4):2073\u201385.","journal-title":"FASEB J"},{"issue":"21","key":"2591_CR77","doi-asserted-by":"publisher","first-page":"e00155","DOI":"10.1128\/MCB.00155-19","volume":"39","author":"M Wang","year":"2019","unstructured":"Wang M, Weng W-C, Stock L, Lindquist D, Martinez A, Gourdon G, et al. Correction of glycogen synthase kinase 3\u03b2 in myotonic dystrophy 1 reduces the mutant RNA and improves postnatal survival of DMSXL mice. Mol Cell Biol. 2019;39(21):e00155\u201319.","journal-title":"Mol Cell Biol"},{"key":"2591_CR78","doi-asserted-by":"crossref","unstructured":"van Engelen B, Abghari S, Aschrafi A, Bouman S, Cornelissen Y, Glennon J, et al. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): Study protocol for randomised controlled trial. Trials. 2015;16:224.","DOI":"10.1186\/s13063-015-0737-7"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02591-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T17:25:32Z","timestamp":1728321932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02591-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02591-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.11.22272021","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The OPTIMISTIC clinical trial (NCT02118779) was conducted in accordance with the Declaration of Helsinki and approved by the medical-ethical scientific committee for human research at each of the four participating clinical centers [\n                      \n                      ]. Prior to participation in the OPTIMISTIC study, all participants had provided written informed consent, including the consent for the use of their pseudo-anonymized blood, urine, and DNA samples. Researchers of this study were not able to link the pseudo-anonymized samples to patient identities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R. van Cruchten reports no disclosures relevant to the manuscript; D. van As reports no disclosures relevant to the manuscript; J.C. Glennon reports no disclosures relevant to the manuscript; B. G. M. van Engelen received fees (to the institution) and non-financial support from Fulcrum Therapeutics, Facio Therapies, and Arrowhead Pharmaceuticals during the conduct of the study. In addition, he received grant support from the FP7 European Union grand OPTIMISTIC, Marigold Foundation Canada, Prinses Beartrix Spierfonds, Spieren voor Spieren, FSHD Stichting, and FSHD Society. He also has an unpaid function as the head of the scientific advisory board for Euro-DyMA. P. A. C. \u2019t Hoen reports no disclosures relevant to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"395"}}